0001213900-23-100077.txt : 20231229 0001213900-23-100077.hdr.sgml : 20231229 20231229172023 ACCESSION NUMBER: 0001213900-23-100077 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231228 FILED AS OF DATE: 20231229 DATE AS OF CHANGE: 20231229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Loughlin Steve CENTRAL INDEX KEY: 0001615840 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36374 FILM NUMBER: 231528646 MAIL ADDRESS: STREET 1: 955 HARTMAN RUN ROAD CITY: MORGANTOWN STATE: WV ZIP: 26507 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Actinium Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001388320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 880378336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PARK AVE., 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (646) 677-3870 MAIL ADDRESS: STREET 1: 100 PARK AVE., 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: Cactus Ventures, Inc. DATE OF NAME CHANGE: 20070130 4 1 ownership.xml X0508 4 2023-12-28 0 0001388320 Actinium Pharmaceuticals, Inc. ATNM 0001615840 O'Loughlin Steve C/O ACTINIUM PHARMACEUTICALS, INC., 100 PARK AVE., 23RD FLOOR NEW YORK, NY 10017 0 1 0 0 Chief Financial Officer 0 Stock Option (Right to Buy) 5.00 2023-12-28 4 A 0 253123 0 A 2033-12-28 Common Stock 253123 253123 D This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant. Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested. /s/ Steve O'Loughlin 2023-12-29